These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 8557411)

  • 1. Syringe exchange: HIV prevention, key findings, and future directions.
    Paone D; Des Jarlais DC; Gangloff R; Milliken J; Friedman SR
    Int J Addict; 1995; 30(12):1647-83. PubMed ID: 8557411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AIDS and injecting drug use in the United Kingdom, 1987-1993: the policy response and the prevention of the epidemic.
    Stimson GV
    Soc Sci Med; 1995 Sep; 41(5):699-716. PubMed ID: 7502102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Operating needle exchange programmes in the hills of Thailand.
    Gray J
    AIDS Care; 1995; 7(4):489-99. PubMed ID: 8547363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of HIV infection and recent risk behaviour among injecting drug users in Berlin by site of recruitment.
    Stark K; Müller R; Wirth D; Bienzle U; Pauli G; Guggenmoos-Holzmann I
    Addiction; 1995 Oct; 90(10):1367-75. PubMed ID: 8616465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Declining risk for HIV among injecting drug users in Kathmandu, Nepal: the impact of a harm-reduction programme.
    Peak A; Rana S; Maharjan SH; Jolley D; Crofts N
    AIDS; 1995 Sep; 9(9):1067-70. PubMed ID: 8527080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The efficacy of needle exchange programs in the prevention of HIV and hepatitis infection among injecting drug users].
    Takács IG; Demetrovics Z
    Psychiatr Hung; 2009; 24(4):264-81. PubMed ID: 19949245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of a pilot study on needle and syringe exchange program among injecting drug users in a community in Guangdong, China].
    Lin P; Fan ZF; Yang F; Wu ZY; Wang Y; Liu YY; Ming ZQ; Li WJ; Luo W; Fu XB; Mai XR; Xu RH; Feng WY; He Q
    Zhonghua Yu Fang Yi Xue Za Zhi; 2004 Sep; 38(5):305-8. PubMed ID: 15498241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Syringe availability as HIV prevention: a review of modalities.
    Coffin P
    J Urban Health; 2000 Sep; 77(3):306-30. PubMed ID: 10976607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage.
    Mathers BM; Degenhardt L; Ali H; Wiessing L; Hickman M; Mattick RP; Myers B; Ambekar A; Strathdee SA;
    Lancet; 2010 Mar; 375(9719):1014-28. PubMed ID: 20189638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.
    Broz D; Wejnert C; Pham HT; DiNenno E; Heffelfinger JD; Cribbin M; Krishna N; Teshale EH; Paz-Bailey G;
    MMWR Surveill Summ; 2014 Jul; 63(6):1-51. PubMed ID: 24990587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coverage to curb the emerging HIV epidemic among injecting drug users in Pakistan: delivering prevention services where most needed.
    Emmanuel F; Fatima M
    Int J Drug Policy; 2008 Apr; 19 Suppl 1():S59-64. PubMed ID: 18281206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Needle and syringe sharing practices among injecting drug users in Tehran: a comparison of two neighborhoods, one with and one without a needle and syringe program.
    Zamani S; Vazirian M; Nassirimanesh B; Razzaghi EM; Ono-Kihara M; Mortazavi Ravari S; Gouya MM; Kihara M
    AIDS Behav; 2010 Aug; 14(4):885-90. PubMed ID: 18483849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies to improve access to sterile syringes for injection drug users.
    Rich JD; Wolf FA; Macalino G
    AIDS Read; 2002 Dec; 12(12):527-35. PubMed ID: 12518719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An external evaluation of a peer-run "unsanctioned" syringe exchange program.
    Wood E; Kerr T; Spittal PM; Small W; Tyndall MW; O'Shaughnessy MV; Schechter MT
    J Urban Health; 2003 Sep; 80(3):455-64. PubMed ID: 12930883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enough sterile syringes to prevent HIV transmission among injection drug users in Montreal?
    Remis RS; Bruneau J; Hankins CA
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S57-9. PubMed ID: 9663625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sterile syringe access conditions and variations in HIV risk among drug injectors in three cities.
    Bluthenthal RN; Malik MR; Grau LE; Singer M; Marshall P; Heimer R;
    Addiction; 2004 Sep; 99(9):1136-46. PubMed ID: 15317634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV incidence among injecting drug users in New York City syringe-exchange programmes.
    Des Jarlais DC; Marmor M; Paone D; Titus S; Shi Q; Perlis T; Jose B; Friedman SR
    Lancet; 1996 Oct; 348(9033):987-91. PubMed ID: 8855855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Harm reduction interventions, behaviours and associated health outcomes in France, 1996-2003.
    Emmanuelli J; Desenclos JC
    Addiction; 2005 Nov; 100(11):1690-700. PubMed ID: 16277629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.
    Birkhead GS; Klein SJ; Candelas AR; O'Connell DA; Rothman JR; Feldman IS; Tsui DS; Cotroneo RA; Flanigan CA
    Int J Drug Policy; 2007 Oct; 18(5):417-25. PubMed ID: 17854731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Barriers to Access to Sterile Syringes as Perceived by Pharmacists and Injecting Drug Users: Implications for Harm Reduction in Lebanon.
    Ghaddar A; Nassar K; Elsoury G
    Subst Use Misuse; 2017 Sep; 52(11):1420-1428. PubMed ID: 28430013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.